FDA inspection
Sanofi Aventis Recherche Develop: FDA inspection ending Dec 9, 2005
FDA inspection 435996 · Voluntary Action Indicated (VAI) · Labege
Key facts
| Inspection ID | 435996 |
|---|---|
| Firm | Sanofi Aventis Recherche Develop |
| FEI number | 1000201561 |
| Address | La Pyreneenne, Quartier Grande Borde |
| City | Labege |
| Fiscal year | 2006 |
| Inspection end date | Dec 9, 2005 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data